Aldeyra therapeutics inc.

Major-Pharmaceuticals

ALDX


131 Hartwell Avenue
Lexington , MA 02421

Executive/
Director

Price

  • Last Close
  • $ 5.23
    $ +0.27 5.44 %
    Dec 6, 2024
  • 52-Week High/Low
  • $7.57 - $1.47
  • YTD
  • 49%

  • Trading Volume
  • 15,277
  • Market Cap Full
  • $ 307.6M
  • Shares Outstanding
  • 58.8M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 41% -38.2% -6.5% 10.3% 8.8% -5% 69.4% 11.1% 42.7% -6.8%
Q2 -23.8% 35.8% -7% 13.6% -28.1% 4% -1.2% -10.2% -15.5% 8.6%
Q3 -24.9% 37.4% 54.8% 71.4% -1.9% 8% -22.2% 33.8% -20.4% -
Q4 16.3% -31.6% -7.5% -36.4% 1.4% -8.6% -54.7% 30.3% -42.1% -
J F M A M J J A S O N D
2024 -10.8% 15.7% -9.7% 8.6% - - - - - - - -
2023 -15.2% 14.6% 46.9% -4% -0.4% -11.6% -3.3% -8.1% -10.5% -74.4% 62% 26.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-6%-21%27%22%-29%15%-41%74%-50%49%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.32 0.51 0.37 -0.43 -0.58 -0.34 -0.25 -0.29 -0.27
Q2 0.27 0.41 0.35 -0.46 -0.49 -0.25 -0.28 -0.3 -0.15
Q3 0.35 0.38 0.32 -0.52 -0.69 -0.23 -0.27 -0.25 -0.14
Q4 0.47 0.36 0.37 -0.38 -0.48 -0.29 -0.27 -0.22 -
A 1.4 1.7 1.4 -1.8 -2.2 -1.1 -1.1 -1.1 -0.56

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 27.4 29.7 47.2 58.1 58.6
Jun 20.1 27.5 29.8 57.6 58.3 58.6
Sep 21 27.6 38.6 57.9 58.3 58.6
Dec 26.2 28 38.8 58.1 58.6 58.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio 0.1 0.1 0.1 0.2 -
Debt – Equity Ratio 0.1 0.1 0.2 0.3 -
Interest Coverage 63 -28 -18 31.5 40
Equity multiplier - - - - -